Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2005  by Fang, H. et al.
ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01941.x
Genetic diversity of community-associated methicillin-resistant
Staphylococcus aureus in southern Stockholm, 2000–2005
H. Fang, G. Hedin, G. Li and C. E. Nord
Department of Clinical Microbiology, Karolinska University Hospital Huddinge, Karolinska Institute,
Stockholm, Sweden
ABSTRACT
This study investigated the molecular epidemiology of 104 community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA) isolates from southern Stockholm during the period 2000–2005. The
isolates were analysed by pulsed-ﬁeld gel electrophoresis (PFGE), multilocus sequence typing,
staphylococcal chromosomal cassette (SCC) mec typing and detection of genes encoding Panton–
Valentine leukocidin (PVL). Overall, 28 distinct PFGE patterns and 13 sequence types (STs) were
identiﬁed. ST80, ST8, ST88 and ST150 were the major CA-MRSA clones in the area, and these accounted
for 75% (78 ⁄ 104) of all CA-MRSA isolates. ST150 isolates, which have, to date, been found only in
Sweden, were isolated exclusively from a group of homeless individuals. Eighty-six (83%) of the 104
isolates in the study possessed SCCmecIV, found in ten different STs, while 16 isolates possessed
SCCmecV. The PVL genes were detected in 56% (58 ⁄ 104) of the isolates. Strain ST80-MRSA-IV carrying
PVL genes predominated over the 6-year period and accounted for 38% of all isolates. However, a
polyclonal tendency was observed among the CA-MRSA isolates recovered in recent years.
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INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA)
has traditionally been considered to be a hospital-
associated pathogen that affects patients with
established risk-factors. However, the emergence
and spread of MRSA in the community has now
become a global reality, and it appears that
community-associated MRSA (CA-MRSA) strains
are now migrating into the hospital setting [1–6].
The prevalence of MRSA varies widely among
countries. Sweden is one of the few countries with
a reputation for controlling MRSA, but the pro-
portions of both hospital-associated and commu-
nity-associated infections caused by MRSA have
been increasing steadily in Sweden and world-
wide [7]. According to a nationwide surveillance
study, the number of reported cases of MRSA
infection in Sweden increased from 325 cases in
2000 to 423 in 2001, 441 in 2002 and 544 in 2003,
corresponding to an overall increase in incidence
from 3.7 to 6.1 ⁄ 100 000 inhabitants [8].
CA-MRSA differs both phenotypically and
genotypically from hospital-associated MRSA
(HA-MRSA). At present, molecular epidemiolog-
ical deﬁnitions, based on staphylococcal chromo-
somal cassette (SCC) mec typing and phylogenetic
analyses of the MRSA isolates, are considered to
be the most reliable means of distinguishing
between CA-MRSA and HA-MRSA. CA-MRSA
usually harbours SCCmecIV or SCCmecV, and is
associated with the genes encoding Panton–
Valentine leukocidin (PVL) [9,10]. Worldwide,
CA-MRSA strains differ in SCCmec type, pulsed-
ﬁeld gel electrophoresis (PFGE) pattern and
multilocus sequence type (ST) [9–15]. The ﬁrst
CA-MRSA strain in the southern Stockholm
region was documented in 2000. The present
study aimed to investigate the molecular epi-
demiology of CA-MRSA in southern Stockholm
during the period 2000–2005.
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MATERIALS AND METHODS
Bacterial strains
The Department of Clinical Microbiology at Karolinska
University Hospital Huddinge serves all healthcare centres
located in southern Stockholm with respect to MRSA
diagnosis and epidemiological analysis. The area has
0.9 million inhabitants. The present study included 104
consecutive, non-duplicate CA-MRSA isolates from southern
Stockholm during the period 2000–2005. New MRSA cases
were deﬁned as patients (MRSA infection) or carriers (MRSA
colonisation) with no previous history of MRSA infection or
colonisation.
CA-MRSA cases were categorised into three groups on the
basis of epidemiological information: (i) community-acquired
cases (n = 83), comprising patients in an outpatient setting or
patients from whom isolates were obtained within 48 h of
hospital admission; these patients had no history in the
previous year of hospitalisation, admission to a nursing
home, dialysis or surgery, and had no permanent indwelling
catheters or medical devices that passed through the skin [9];
(ii) family-transmitted cases (n = 10), in which the same
MRSA clone had spread within a family, and where the
patients had a history of hospitalisation within the past year;
and (iii) a group of homeless individuals (n = 11) who stayed
at hostels with other homeless individuals. Isolates from the
latter two groups were acquired outside a healthcare setting;
therefore, they were considered to be community-associated
and were included in the study. All CA-MRSA isolates were
identiﬁed by standard biochemical tests, followed by a
duplex PCR to conﬁrm the presence of the mecA and nuc
genes [16].
PFGE
All isolates were genotyped by PFGE after macrorestriction
with SmaI. S. aureus CCUG 41582 was included as a control
strain. The PFGE banding patterns were analysed using
GelCompar II (Applied Maths, Sint-Martins-Latem, Belgium)
with the Dice coefﬁcient and the unweighted pair-group
method using arithmetic averages (UPGMA). Each banding
pattern was assigned a clone designation if two or more
isolates were found to have the same pattern in the study, or
was considered to be unique. PFGE clones were designated
MRSA, the year when the second isolate (regardless of
whether it was CA-MRSA or HA-MRSA) with the same
pattern was isolated, and the running number of the new
clones detected during the year (e.g., MRSA-01-04 was the
fourth PFGE clone of MRSA designated in 2001).
SCCmec typing
SCCmec typing was ﬁrst performed using the multiplex PCR
assay described by Oliveira and Lencastre [17]. All the
type IV isolates and the isolates with novel patterns were
then further typed using PCR assays for characterisation of
the mec gene and ccr gene complexes, as described by Zhang
et al. [18].
Multilocus sequence typing (MLST)
MLST was performed on 31 isolates, including examples of
each distinct PFGE pattern with distinct SCCmec types, as well
as the two MRSA-03-03 isolates carrying SCCmecV (Table 1).
MLST was performed according to Enright et al. [19].
Table 1. Molecular characteristics of 104 community-associated methicillin-resistant Staphylococcus aureus (MRSA)
isolates recovered in southern Stockholm during the period 2000–2005
MLST PFGE typea PVL genes SCCmec type
No. of isolates
Year(s) of isolationCommunity-acquired Family-transmitted Homeless individuals
ST5 MRSA-01-09 ) IV 2 2001, 2003
Unique ) IV 3 2002, 2004, 2005
Unique ) V 1 2004
ST8 MRSA-01-02 + IV 10 2001, 2002, 2004, 2005
MRSA-05-05 ) IV 1 2 2005
Unique + IV 3 2003, 2005
Unique ) IV 1 2005
ST22 MRSA-97-01 ) IV 1 2 2005
Unique ) IV 2 2005
ST30 Unique + IV 1 2001
ST45 MRSA-01-01 ) IV 3 2004, 2005
ST59 MRSA-01-08 + V 2 2001
ST72 MRSA-05-06 ) IV 1 1 2005
ST72 slv Unique ) IV 1 2005
ST80 MRSA-01-04 + IV 33 4b 2000–2005
MRSA-01-05 + IV 2 2001
ST88 MRSA-98-02 ) IV 3 1 2004
MRSA-03-03 ) IV 7 2000, 2003, 2004
ST97 MRSA-05-09 ) IV 2 2005
ST150 MRSA-02-01 ) V 5 2002, 2003
MRSA-02-01 ) Novel 2 2002
MRSA-03-03 ) V 2 2003
MRSA-04-06 ) V 2 2004, 2005
ST152 MRSA-04-09 + V 3 2004, 2005
Unique ) V 1 2005
aThe PFGE types termed unique were all distinct in their banding patterns, but were categorised according to their MLST, PVL gene and SCCmec types.
bTwo isolates were detected in 2004 and another two in 2005.
MLST, multilocus sequence typing; PFGE, pulsed-ﬁeld gel electrophoresis; PVL, Panton–Valentine leukocidin; SSCmec, staphylococcal chromosomal cassette mec; ST, sequence
type.
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Detection of genes encoding PVL
The presence of the genes encoding PVL was detected using
the PCR assay described by Lina et al. [20]. S. aureus CCUG
46923 was used as a positive control strain.
RESULTS
The number of newly detected MRSA cases in the
area increased from 30 in 2000 to 105 in 2005,
corresponding to an increase in incidence from 3.3
to 11.7 ⁄ 100 000 inhabitants. Concomitantly,
the proportion of community-associated isolates
increased, from 7% (2 ⁄ 30) in 2000 to 27% (11 ⁄ 41)
in 2001, 25% (13 ⁄ 52) in 2002, 20% (11 ⁄ 58) in 2003,
35% (28 ⁄ 81) in 2004 and 37% (39 ⁄ 105) in 2005.
Eighty-three (80%) of the 104 CA-MRSA iso-
lates investigated were acquired in the commu-
nity, without any known risk-factors for MRSA
acquisition. The isolates categorised as family-
transmitted involved individuals who were
infected or colonised by the same MRSA clone
as their family members (Table 1). Six of the
family-transmitted isolates were colonisers, and
four were from clinical infections. These isolates
belonged to ST8, ST22, ST72, ST80 and ST88
(Table 1). The MRSA isolates from homeless
individuals all belonged to ST150, which was a
unique ST that was characteristic of this group
(Table 1).
PFGE analysis revealed 28 distinct banding
patterns among the 104 CA-MRSA isolates,
including 15 clones represented by at least two
isolates, and 13 isolates with unique patterns.
Thirteen STs were identiﬁed by MLST (Table 1,
Fig. 1). ST80, ST8, ST88 and ST150 were the
major CA-MRSA clones, together accounting for
75% (78 ⁄ 104) of the CA-MRSA isolates investi-
gated during the 6-year period (2000–2005).
ST80 isolates predominated throughout this
period, accounting for one of the two CA-MRSA
strains in 2000, 27% (3 ⁄ 11) in 2001, 31% (4 ⁄ 13)
in 2002, 27% (3 ⁄ 11) in 2003, 43% (12 ⁄ 28) in
2004, and 41% (16 ⁄ 39) in 2005. Although ST80
isolates predominated throughout the period,
a tendency towards increased diversity was
observed for recent years, with nine and 17
different PFGE patterns being identiﬁed in 2004
and 2005, respectively, compared with a total of
ten PFGE patterns during the period 2000–2003.
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Fig. 1. Examples of the 28 distinct
SmaI pulsed-ﬁeld gel electrophoresis
patterns detected among 104 com-
munity-associated MRSA isolates,
showing their corresponding
sequence types (ST). Isolates were
clustered using the Dice coefﬁcient
and the unweighted pair-group
method with average linkage
(UPGMA).
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The number of STs in each year from 2000 to
2005 was two, ﬁve, four, ﬁve, seven and ten,
respectively.
Eighty-six (83%) of the 104 isolates in the study
harboured SCCmecIV, which was found in ten STs
(ST5, ST8, ST22, ST30, ST45, ST72, single-locus
variant of ST72, ST80, ST88 and ST97). Sixteen
isolates harbouring SCCmecV were found in four
STs, namely ST5, ST59, ST150 and ST152.
Among the 83 community-acquired isolates,
92% (76 ⁄ 83) and 8% (7 ⁄ 83) harboured SCCmecIV
and SCCmecV, respectively. The PVL genes were
found in 65% (54 ⁄ 83) of the isolates (Table 1).
The ten family-transmitted isolates all possessed
SCCmecIV. PVL genes were detected in four
isolates belonging to PFGE type MRSA-01-04 and
ST80 (Table 1). Nine of the 11 isolates from the
group of homeless individuals carried SCCmecV.
The two remaining isolates had a unique SCCmec
pattern that could not be assigned to any of the
known types according to the assays used in this
study. No PVL genes were detected in isolates
belonging to this group (Table 1). Overall, it
appeared that the presence of the PVL genes was
associated with the PFGE pattern; i.e., isolates
with the same PFGE pattern were consistent in
terms of the presence or absence of PVL
(Table 1).
DISCUSSION
The worldwide emergence of CA-MRSA is a
threat to individuals in both the community and
the hospital environment, since these strains
appear to be more virulent than HA-MRSA
strains, and have the ability to cause skin and
soft-tissue infections in otherwise healthy indi-
viduals [9,10,21,22]. Worldwide, the ﬁrst commu-
nity-acquired MRSA strain was reported in
Western Australia during 1993 in patients from
remote communities with no known risk-factors
for MRSA colonisation [23]. The ﬁrst two
CA-MRSA cases in southern Stockholm were
notiﬁed in 2000, and also had no known risk-
factors. The two isolates belonged to clones ST88-
MRSA-IV and ST80-MRSA-IV. Subsequently, the
number of newly detected cases involving MRSA
has increased annually, and the proportion of
CA-MRSA among the total number of MRSA
isolates has also risen, but the extent to which this
increase can be attributed to increased screening
over the years is difﬁcult to quantify.
ST80-MRSA-IV carrying PVL genes was
the most prominent CA-MRSA clone (38%)
detected in southern Stockholm, followed by
ST8-MRSA-IV (16%), ST88-MRSA-IV (11%) and
ST150-MRSA-V ⁄variant (11%) (Table 1). The pre-
dominance of the ST80-MRSA-IV clone in this
region was in accord with a Danish study [24], but
a study from Norway [14] reported that ST8
(40%), followed by ST80 (19%), predominated
among 67 MRSA isolates, the majority of which
were CA-MRSA, in northern Norway during the
period 1995–2003.
The study also revealed that ST22 and ST45,
which are usually hospital-associated clones, had
appeared among community-associated isolates
since 2004. In addition, seven of the isolates in the
family-transmitted group belonged to ST80, ST8
and ST88, which are the major CA-MRSA clones
in the area. It is probable that family-transmitted
CA-MRSA could enter hospital settings following
the hospitalisation of a family member; indeed,
there have been frequent reports in recent years
that clones considered previously to spread
mainly in the community are now emerging in
healthcare settings [3–6], and that the divisions
between CA-MRSA and HA-MRSA are now
becoming indistinct.
Among the 28 distinct PFGE patterns and 13
STs identiﬁed in the study, closely related PFGE
patterns were generally assigned to the same ST
(Fig. 1). An exception comprised isolates belong-
ing to MRSA-03-03, which were classiﬁed as
either ST88 or ST150 (Table 1). ST88 and ST150
are double-locus variants, and possess different
SCCmec types (Table 1). Isolates with the same
PFGE pattern were also consistent with respect to
the presence or absence of the PVL genes. Since
an ST may include more than one PFGE type, it
seems that PFGE has a higher discriminatory
power than does MLST for MRSA genotyping.
To date, at least ﬁve SCCmec types (I–V) and
several variants have been described. Although
the distinction between CA-MRSA andHA-MRSA
based on the SCCmec type is beginning to blur, it
appears that well-deﬁned CA-MRSA isolates
mainly carry SCCmecIV or SCCmecV, whereas
most HA-MRSA isolates carry SCCmecI, SCCmecII
or SCCmecIII [10,14,17,25–30]. In the present
study, all isolates harboured SCCmecIV or
SCCmecV, except for two ST150 ⁄MRSA-02-01
isolates (Table 1), which had a novel proﬁle
according to the multiplex PCR assay of Oliveira
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and de Lancastre [17]. This novel SCCmec type is
probably a variant of SCCmecV, since its pattern
was similar to that of type V isolates, and isolates
with the same PFGE type (MRSA-02-01) were also
found to possess SCCmecV. Sixteen SCCmecV
isolates were found in four STs, namely ST5,
ST59, ST150 and ST152. ST5 isolates with
SCCmecV have been reported in Australia, ST59
in Australia, Taiwan and Singapore, and ST152 in
Kosovo and Australia [9,12,13,15,31]. To date,
ST150 isolates have only been found in Sweden.
SCCmecIV and SCCmecV are relatively small in
size; in the case of SCCmecIV, this appears to have
resulted in increased mobility and, therefore,
greater potential for horizontal spread to diverse
S. aureus genetic backgrounds. The present study
provided further evidence for the horizontal
spread of SCCmecIV and SCCmecV among multi-
ple lineages of S. aureus [9,13,14,30].
There are conﬂicting reports as to whether a
relationship exists between SCCmecIV and
production of PVL [11,32–34]. PVL is a
S. aureus-speciﬁc exotoxin that is associated with
skin and soft-tissue infections and severe necro-
tising pneumonia [11,20]. In general, <5% of
MRSA strains with SCCmecI–III carry PVL, while
40–90% of MRSA strains that harbour SCCmecIV
carry PVL [35]. The relationship between
SCCmecV and PVL in CA-MRSA strains remains
unclear [9,10]. In the present study, 64% (49 ⁄ 76)
of the community-acquired isolates harbouring
SCCmecIV carried the PVL genes, and these genes
were also detected in 71% (5 ⁄ 7) of the isolates
harbouring SCCmecV. It was shown in a previous
study that 96% of PVL-positive MRSA isolates
were community-associated, while 81% of PVL-
negative MRSA isolates were hospital-associated
[7]. Thus, the presence of PVL and SCCmecIV or
SCCmecV might be indicative of a community
origin for MRSA isolates in Sweden.
ST150 was isolated from a group of homeless
individuals. This clone was not encountered in the
hospital setting in Sweden, and has not, to date,
been reported from other countries contributing to
the MLST database (http://www.mlst.net). Com-
bined with the presence of the SCCmecV ⁄variant
in this clone, the ST150-MRSA-V ⁄ variant from the
group of homeless individuals was categorised as
community-associated.
ST59-MRSA-V is a predominant CA-MRSA
clone in Taiwan [12,15], and has a resistance
phenotype that differs from the usual CA-MRSA
strains. Such isolates are resistant to macrolide,
lincosamide and streptogramin B antibiotics, as
well as b-lactam antibiotics. Accordingly, the
ST59-MRSA-V isolates detected in Stockholm
were also resistant to clindamycin, as well as to
tetracycline. The presence of the PVL genes is
another common characteristic of this multiresis-
tant CA-MRSA clone.
Mu¨ller-Premru et al. [36] were the ﬁrst to detect
PVL in CA-MRSA isolates belonging to ST5 and
ST152, which were associated with an outbreak of
severe soft-tissue infection in a football team in
Slovenia [36]. The emergence of PVL in MRSA
isolates belonging to ST5 is of particular concern
because of the epidemic potential of this strain
(ST5-MRSA-I), which is also known as the UK
EMRSA-3 clone. In the present study, no ST5
isolate was found to harbour the PVL genes, but
such a strain has recently emerged in the southern
Stockholm area (personal unpublished data).
Three ST152 isolates with SCCmecV were found
to harbour PVL genes in the present study. The
PVL-positive MRSA isolates belonging to ST5 or
ST152 emerged in Stockholm during 2004, which
is the same year during which the outbreak
occurred in Slovenia.
Despite the recognition of diverse CA-MRSA
clones in Sweden, the overall prevalence of MRSA
in Sweden remains low [8], which could be at
least partially, if not totally, attributed to infection
control measures. The number of screening cul-
tures for MRSA at our laboratory rose from
<1000 cultures ⁄ year in 2000 to 13 411 cul-
tures ⁄ year in 2003, to 47 871 cultures ⁄ year in
2004, and to 57 191 cultures ⁄ year in 2005. From
1 January 2000, notiﬁcation of MRSA carriage ⁄
disease has been mandatory according to the
Swedish Communicable Disease Act. When a
positive MRSA culture is obtained, a patient is
recorded as MRSA-positive in his ⁄her medical
history, and the patient should then be isolated in
a single room whenever admitted to a hospital or
healthcare facility. Control of MRSA relies pre-
dominantly on strict adherence to fundamental
infection control procedures, including hand
hygiene guidelines and the use of protective
clothing. Antibiotic treatment to eradicate MRSA
from colonised individuals is not usually under-
taken in Stockholm.
In conclusion, although the overall prevalence
of MRSA in Sweden remains low, an increasing
number of MRSA strains, especially community-
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associated isolates, has been notiﬁed recently,
which might be attributed, at least in part, to
increased screening for MRSA. ST80-MRSA-IV
carrying PVL genes is the predominant CA-
MRSA clone in southern Stockholm, followed by
ST8-IV, ST88-IV and ST150-V ⁄ variant. A poly-
clonal tendency seems to have emerged among
the CA-MRSA isolates obtained in recent years.
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